PrescriptionNCT01668810
The Third Survey of Prescription Pattern of Psychotropic Drugs in China
An observational study of Prescription, run by Peking University at 1 site in China.
Trial summary
The investigators aimed to examine the psychotropic prescription pattern in China. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Prescription
- How many people
- 7,000 participants
- Where
- 1 siteChina
- Study dates
- Jul 2012to Jul 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: schizophrenia, depression and bipolar disorder patients
Who may be able to join
None listed.
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Institute of mental health, Peking University
Beijing, Beijing Municipality, 100191
Tianmei Si, PhD., 8610-82801960, si.tian-mei@163.com
Tianmei Si, PhD.
About this study
Official title: The Third Survey on China Psychotropic Prescription for Schizophrenia, Depression and Bipolar Disorder
The investigators aimed to examine the psychotropic prescription pattern in China.
- Conditions
- Prescription
- Keywords
- prescription, schizophrenia, depression, bipolar disorder
- Medical subject headings
- Schizophrenia, Depression, Bipolar Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Beijing region | include six hospitals | |
| Guangdong Province | include 3 hospitals | |
| Jiangsu province | include 3 hospitals | |
| Hebei province | include 6 hospitals | |
| Hubei Province | include 7 hospitals | |
| Shanxi province | include 3 hospitals | |
| Jiangxi province | include 3 hospitals | |
| Jilin province | include 6 hospitals | |
| Sichuan province | include 3 hospitals | |
| Shaanxi province | include 3 hospitals |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2012 (estimated)
- Study startJul 2012
- Primary completionSep 2012 (estimated)
- Study completionJul 2013 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PrescriptionStudies of the same condition, open and under way.
- More trials run by Peking UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Enrolment
- 7,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Peking University
- Sponsor type
- University, hospital or other
- Collaborators
- Xian-Janssen Pharmaceutical Ltd.
- Responsible party
- Principal investigator, Si Tianmei, Peking University
- Investigators
- Xin Yu, MD., Study chair, Peking University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01668810
- Sponsor's protocol ID
- RISSCH4255
- Status last verified
- Jul 2012
- First submitted
- 16 Aug 2012
- Last updated
- 20 Aug 2012
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Third Survey on China Psychotropic Prescription for Schizophrenia, Depression and Bipolar Disorder
- ClinicalTrials.gov ID
- NCT01668810
- Acronym / sponsor ID
- RISSCH4255
- Conditions
- Prescription
- Keywords
- prescription, schizophrenia, depression, bipolar disorder
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 7,000 participants (estimated)
- Lead sponsor
- Peking UniversityUniversity, hospital or other
- Collaborators
- Xian-Janssen Pharmaceutical Ltd.
- Study start
- Jul 2012
- Primary completion
- Sep 2012 (estimated)
- Study completion
- Jul 2013 (estimated)
- First posted
- 20 Aug 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators aimed to examine the psychotropic prescription pattern in China.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Number of arms
- 10
| Arm | Type | Receives |
|---|---|---|
| Beijing region | – | –include six hospitals |
| Guangdong Province | – | –include 3 hospitals |
| Jiangsu province | – | –include 3 hospitals |
| Hebei province | – | –include 6 hospitals |
| Hubei Province | – | –include 7 hospitals |
| Shanxi province | – | –include 3 hospitals |
| Jiangxi province | – | –include 3 hospitals |
| Jilin province | – | –include 6 hospitals |
| Sichuan province | – | –include 3 hospitals |
| Shaanxi province | – | –include 3 hospitals |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- schizophrenia, depression and bipolar disorder patients
Key inclusion criteria (0 listed)
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2012.
Related trials for Prescription
Not yet recruiting
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
HIV Testing, STI
Not yet recruiting
Days-Off Versus Daily Initial Peritoneal Dialysis Prescription
Kidney Failure
Not yet recruitingObservational study
Disease Intervention Specialist (DIS) for SUD
Substance Use Disorder (SUD), Opioid Use Disorder
Not yet recruiting
SWitching to Appropriate Prescription in Cardiovascular-Kidney-Metabolic Syndrome
Cardiovascular-kidney-metabolic Syndrome, Diabete Type 2
Not yet recruiting
Threshold-Based Versus Range-Based Exercise Intensity Prescription in Cardiac Rehabilitation
Cardiovascular Diseases, Cardiac Rehabilitation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Xin Yu, MD. study chair
Peking University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Prescription, run by Peking University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 20 Aug 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Yun-Ai Su, Phd. (8610-82801960, suyunai@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2012.